Streetbeat News

Corporate Responsibility

MOG/A

MOG/B

Moog's board has officially approved the appointment of Pat Roche as President of the company, in addition to his current role as CEO, according to an SEC filing on Feb 6.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 6:44 pm

MSTR

MicroStrategy Inc. co-founder Michael Saylor emphasized Bitcoin's potential as an institutional asset class and store of value, predicting 2024 as the year Bitcoin becomes an institutional-grade asset. He compared Bitcoin's evolution to significant financial milestones like the creation of gold ETFs and the S&P index ETF. Saylor highlighted Bitcoin's transition from an unregulated retail asset to a regulated institutional asset, likening it to the digital transformation seen in tech companies like Microsoft, Google, and Apple. He also mentioned the growth of new job opportunities within the Bitcoin industry and argued that Bitcoin ETFs represent a catalytic moment, shifting the narrative towards Bitcoin as a significant store of value.

Portfolio Pulse from Murtuza Merchant

February 07, 2024 | 5:42 pm

FCX

Freeport-McMoRan (NYSE:FCX) announced Kathleen L. Quirk as its new CEO, effective June 11. Quirk, with the company since 1989 and previously CFO and President, succeeds Richard Adkerson, who remains Chairman. The leadership transition is part of a strategic plan, with Quirk's extensive experience expected to continue Freeport's successful trajectory in the mining industry. The company anticipates $5.8 billion in operating cash flows in 2024, with significant sales volumes of copper, gold, and molybdenum.

Portfolio Pulse from Stjepan Kalinic

February 07, 2024 | 5:23 pm

AULT

Ault Alliance Inc (NASDAQ:AULT) shares surged 25.3% to $0.44 after announcing it will not pursue new acquisitions in 2024, focusing on maximizing the value of its existing assets including a data center, crane rental business, and lending company. The company plans to reduce headcount to save over $2 million in payroll expenses. This decision is part of Ault Alliance's strategy to enhance portfolio value and support sustained growth, as stated by Executive Chairman Milton "Todd" Ault III.

Portfolio Pulse from Henry Khederian

February 07, 2024 | 4:45 pm

HLT

On CNBC, Hilton's CEO Christopher Nassetta discussed the company's earnings and provided guidance for the future. He highlighted key financial results and strategic plans aimed at driving growth.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:26 pm

NVDA

OPRA

Opera (NASDAQ:OPRA) is set to deploy a green energy-powered AI data cluster in Keflavik, Iceland, featuring an NVIDIA DGX SuperPOD. This initiative, starting in February 2024, aims to enhance Opera's browsers with advanced AI capabilities, including the Aria Browser AI. The cluster will be powered by renewable energy sources and equipped with NVIDIA's latest H100 Tensor Core GPUs, significantly boosting AI training and inference speeds. This move underscores Opera's commitment to environmental sustainability and its ambition to lead in browser AI innovation.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 3:30 pm

AAPL

ISS, a proxy advisory group, has recommended that Apple shareholders vote in favor of two shareholder proposals. The first proposal calls for a report on the median gender and racial pay gap within the company. The second proposal seeks a report on the use of artificial intelligence by Apple. These recommendations were reported by Reuters.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 3:25 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) shares surged after reporting Q4 financial results, despite missing earnings and revenue estimates. The stock was upgraded by Oppenheimer and had its price target raised by BMO Capital. The company plans to cease operations in Romania and Wisconsin, focusing on manufacturing in the U.S. Short interest in ENPH shares may also be influencing its price movement.

Portfolio Pulse from Erica Kollmann

February 07, 2024 | 3:20 pm

GILD

Gilead Sciences is currently reviewing the safety of Magrolimab in all ongoing solid tumor trials and has committed to providing an update on this assessment as soon as possible, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 3:16 pm

GILD

Gilead Sciences announced that its drug Magrolimab, when combined with Venetoclax and Azacitidine, showed futility and an increased risk of death in AML patients. Consequently, Gilead will halt further development of Magrolimab for hematologic cancers.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 3:16 pm